OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response...10.4

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Global Med Technologies, Inc.

(Name of Issuer)

Common Stock, $.01 par value

(Title of Class of Securities)

37935E101

(CUSIP Number)

September 19, 2007

(Date of Event Which Requires Filing of this Statement)

     Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o       Rule 13d-1(b)
þ       Rule 13d-1(c)
o       Rule 13d-1(d)

     *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No.		37935E101

*

Excludes 6,891,058 shares issuable upon exercise of a warrant to acquire 4,125,000 shares of common stock of Global Med Technologies, Inc. (“Common Stock”) and convertible preferred stock convertible into 5,500,000 shares of Common Stock, which are subject to so called “blocker” provisions prohibiting the holder from exercising the warrant or converting the preferred stock, as applicable, to the extent that such exercise would result in the holder being deemed the beneficial owner of more than 9.99% of the issued and outstanding shares of Common Stock.

CUSIP No.		37935E101

*

Excludes 6,891,058 shares issuable upon exercise of a warrant to acquire 4,125,000 shares of common stock of Global Med Technologies, Inc. (“Common Stock”) and convertible preferred stock convertible into 5,500,000 shares of Common Stock, which are subject to so called “blocker” provisions prohibiting the holder from exercising the warrant or converting the preferred stock, as applicable, to the extent that such exercise would result in the holder being deemed the beneficial owner of more than 9.99% of the issued and outstanding shares of Common Stock.

CUSIP No.		37935E101

*

Excludes 6,891,058 shares issuable upon exercise of a warrant to acquire 4,125,000 shares of common stock of Global Med Technologies, Inc. (“Common Stock”) and convertible preferred stock convertible into 5,500,000 shares of Common Stock, which are subject to so called “blocker” provisions prohibiting the holder from exercising the warrant or converting the preferred stock, as applicable, to the extent that such exercise would result in the holder being deemed the beneficial owner of more than 9.99% of the issued and outstanding shares of Common Stock.

CUSIP No.		37935E101

*

Excludes 6,891,058 shares issuable upon exercise of a warrant to acquire 4,125,000 shares of common stock of Global Med Technologies, Inc. (“Common Stock”) and convertible preferred stock convertible into 5,500,000 shares of Common Stock, which are subject to so called “blocker” provisions prohibiting the holder from exercising the warrant or converting the preferred stock, as applicable, to the extent that such exercise would result in the holder being deemed the beneficial owner of more than 9.99% of the issued and outstanding shares of Common Stock.

CUSIP No.		37935E101

Item 1(a)		Name of Issuer:
		Global Med Technologies, Inc. (the “Issuer”)
Item 1(b)		Address of Issuer’s Principal Executive Offices:
		12600 West Colfax, Suite C-420 Lakewood, Colorado 80215
Item 2(a)		Name of Person Filing:
		Victory Park Capital Advisors, LLC Victory Park Master Fund, Ltd. Jacob Capital, L.L.C. Richard Levy
		Victory Park Capital Advisors, LLC is the investment manager for Victory Park Master Fund, Ltd. Jacob Capital, L.L.C. is the manager of Victory Park Capital Advisors, LLC. Richard Levy is the sole member of Jacob Capital, L.L.C.
Item 2(b)		Address of Principal Business Office or, if none, Residence:
		The business address for each of the reporting persons, other than Victory Park Master Fund, Ltd., is 227 West Monroe Street, Suite 3900, Chicago, Illinois 60606. The business address for Victory Park Master Fund, Ltd. is c/o Walkers SPV Limited, Walker House, 87 Mary Street, George Town, Grand Cayman, KY1 9002 Cayman Islands.
Item 2(c)		Citizenship:
		Victory Park Capital Advisors, LLC is a Delaware limited liability company. Victory Park Master Fund, Ltd. is a Cayman Islands exempted company. Jacob Capital, L.L.C. is an Illinois limited liability company. Richard Levy is a citizen of the United States.
Item 2(d)		Title of Class of Securities:
		Common Stock, par value per share $.01
Item 2(e)		CUSIP Number:
		37935E101
Item 3.		If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
		Not Applicable
Item 4.		Ownership
		As of September 19, 2007:

CUSIP No.		37935E101

(a)

Amount beneficially owned:

Victory Park Capital Advisors, LLC		2,829,942 shares
Victory Park Master Fund, Ltd.		2,829,942 shares
Jacob Capital, L.L.C.		2,829,942 shares
Richard Levy		2,829,942 shares

     Each of the reporting persons may be deemed to be the beneficial owner of a warrant to acquire 4,125,000 shares of the Issuer’s common stock and convertible preferred stock convertible into 5,500,000 shares of the Issuer’s common stock. Victory Park Master Fund, Ltd. is the record holder of the securities reported herein. The warrant and the convertible preferred stock each contain a contractual provision blocking exercise of the warrant and conversion of the convertible preferred stock when the holder beneficially owns more than 9.99% of the issued and outstanding shares of the Issuer. Accordingly, based on the number of outstanding shares of the Issuer’s common stock as reported in the Issuer’s Quarterly Report on Form 10-Q for the period ended June 30, 2007, 6,891,058 of the shares underlying the warrant and the preferred stock are not exercisable and consequently, the shares underlying them have not been included in the number of shares beneficially owned by the reporting persons.

(b)

Percent of class:

Victory Park Capital Advisors, LLC			9.9	%
Victory Park Master Fund, Ltd.			9.9	%
Jacob Capital, L.L.C.			9.9	%
Richard Levy			9.9	%

(c)

Number of shares as to which the person has:

(i)

Sole power to vote or to direct the vote

Victory Park Capital Advisors, LLC		0 shares
Victory Park Master Fund, Ltd.		0 shares
Jacob Capital, L.L.C.		0 shares
Richard Levy		0 shares

(ii)

Shared power to vote or to direct the vote

Victory Park Capital Advisors, LLC		2,829,942 shares
Victory Park Master Fund, Ltd.		2,829,942 shares
Jacob Capital, L.L.C.		2,829,942 shares
Richard Levy		2,829,942 shares

(iii)

Sole power to dispose or direct the disposition of

Victory Park Capital Advisors, LLC		0 shares
Victory Park Master Fund, Ltd.		0 shares
Jacob Capital, L.L.C.		0 shares
Richard Levy		0 shares

(iv)

Shared power to dispose or to direct the disposition of

Victory Park Capital Advisors, LLC		2,829,942 shares
Victory Park Master Fund, Ltd.		2,829,942 shares
Jacob Capital, L.L.C.		2,829,942 shares
Richard Levy		2,829,942 shares

CUSIP No.		37935E101

Item 5.		Ownership of Five Percent or Less of a Class
		Not applicable.
Item 6.		Ownership of More than Five Percent on Behalf of Another Person
		Not Applicable.
Item 7.		Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
		Not Applicable.
Item 8.		Identification and Classification of Members of the Group
		Not Applicable.
Item 9.		Notice of Dissolution of Group
		Not Applicable.
Item 10.		Certification
		By signing below each of Victory Park Capital Advisors, LLC, Victory Park Master Fund, Ltd., Jacob Capital, L.L.C. and Richard Levy certify that, to the best of such reporting person’s knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

     After reasonable inquiry and to the best of their knowledge and belief, each of Victory Park Capital Advisors, LLC, Victory Park Master Fund, Ltd., Jacob Capital, L.L.C. and Richard Levy certify that the information set forth in this statement is true, complete and correct.

CUSIP No.		37935E101

Exhibit 1

JOINT FILING AGREEMENT

     In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the common stock of Global Med Technologies, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement this 31^st day of December, 2007.

		VICTORY PARK CAPITAL ADVISORS, L.L.C.
		By:		Jacob Capital , L.L.C., its Manager
		By:		/s/ Richard Levy
		Name:		Richard Levy
		Title:		Sole Member
		VICTORY PARK MASTER FUND, LTD.
		By:		/s/ Richard Levy
		Name:		Richard Levy
		Title:		Attorney-in-Fact
		JACOB CAPITAL, L.L.C.
		By:		/s/ Richard Levy
		Name:		Richard Levy
		Title:		Sole Member
		By:		/s/ Richard Levy
				Richard Levy

Exhibit 2

POWER OF ATTORNEY
FOR CERTAIN FILINGS
UNDER THE SECURITIES EXCHANGE ACT OF 1934

     Ronan Guilfoyle and Roger H. Hanson, each hereby make, constitute and appoint each of:

     Richard Levy, and

     Matthew Ray,

acting individually, as each of our agents and attorneys-in-fact, with full power of substitution, for the purpose of, from time to time, executing in either of our names and/or our capacities as directors of Victory Park Master Fund, Ltd. all documents, certificates, instruments, statements, other filings, and amendments to the forgoing (collectively, “documents”) determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including without limitation Forms 3, 4, 5, 13D, 13F, and 13G required to be filed with the Securities and Exchange Commission; and delivering, furnishing or filing any such documents with the appropriate governmental or regulatory authority. Any such determination shall be conclusively evidenced by such person’s execution, delivery, furnishing, and/or filing of the applicable document.

IN WITNESS HEREOF, I have executed this instrument as of the date set forth below.

Date: September 28, 2007

/s/ Ronan Guilfoyle
Ronan Guilfoyle,
as Director of Victory Park Master Fund, Ltd.
/s/ Roger H. Hanson
Roger H. Hanson,
as Director of Victory Park Master Fund, Ltd.